VF
DCPH

Virtu Financial’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Virtu Financial’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,372
Closed -$364K – 2144
2020
Q4 		$364K Buy
+6,372
New +$378K 0.04% 555
2019
Q4 		$370K Buy
+5,939
New +$282K 0.04% 565

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Virtu Financial's DCPH Position: Q1 2021 in Review

Virtu Financial sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2021, closing a stake of 6,372 shares — an estimated $364K sold.

Virtu Financial first reported a position in DCPH in Q4 2019 and held it in 2 quarters. The position peaked at $370K in Q4 2019. 167 funds tracked by Wall St. Rank hold DCPH as of Q1 2021.

  • Virtu Financial reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Virtu Financial sold 6,372 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $364K.
  • Virtu Financial first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Virtu Financial's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $370K in Q4 2019.
  • 167 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on Virtu Financial's 13F filing for Q1 2021, filed 19 May 2021.